Sahajwalla C - Search Results

1

Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.

Hutabarat RM, Unadkat JD, Sahajwalla C, McNamara S, Ramsey B, Smith AL. Hutabarat RM, et al. Among authors: sahajwalla c. Clin Pharmacol Ther. 1991 Apr;49(4):402-9. doi: 10.1038/clpt.1991.47. Clin Pharmacol Ther. 1991. PMID: 2015729

2

Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes.

Zhuang L, Chen J, Yu J, Marathe A, Sahajwalla C, Borigini M, Maynard J, Burckart GJ, Wang Y. Zhuang L, et al. Among authors: sahajwalla c. Clin Pharmacol Ther. 2019 Sep;106(3):557-567. doi: 10.1002/cpt.1302. Epub 2019 Jan 28. Clin Pharmacol Ther. 2019. PMID: 30447083 Review.

3

Drug-Drug Interaction Studies of Methadone and Antiviral Drugs: Lessons Learned.

Younis IR, Lakota EA, Volpe DA, Patel V, Xu Y, Sahajwalla CG. Younis IR, et al. J Clin Pharmacol. 2019 Aug;59(8):1035-1043. doi: 10.1002/jcph.1405. Epub 2019 Apr 11. J Clin Pharmacol. 2019. PMID: 30973652 Review.

4

Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.

Booth BP, Rahman A, Dagher R, Griebel D, Lennon S, Fuller D, Sahajwalla C, Mehta M, Gobburu JV. Booth BP, et al. Among authors: sahajwalla c. J Clin Pharmacol. 2007 Jan;47(1):101-11. doi: 10.1177/0091270006295789. J Clin Pharmacol. 2007. PMID: 17192508 Clinical Trial.

5

Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 20-mg/kg intravenous dose.

Sahajwalla CG, Helton ED, Purich ED, Hoppel CL, Cabana BE. Sahajwalla CG, et al. J Pharm Sci. 1995 May;84(5):634-9. doi: 10.1002/jps.2600840521. J Pharm Sci. 1995. PMID: 7658357

6

Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.

Mahmood I, Sahajwalla C. Mahmood I, et al. Among authors: sahajwalla c. Clin Pharmacokinet. 1999 Apr;36(4):277-87. doi: 10.2165/00003088-199936040-00003. Clin Pharmacokinet. 1999. PMID: 10320950 Review.

7

Interspecies scaling of biliary excreted drugs.

Mahmood I, Sahajwalla C. Mahmood I, et al. Among authors: sahajwalla c. J Pharm Sci. 2002 Aug;91(8):1908-14. doi: 10.1002/jps.10174. J Pharm Sci. 2002. PMID: 12115817

8

Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers.

Sahajwalla CG, Helton ED, Purich ED, Hoppel CL, Cabana BE. Sahajwalla CG, et al. J Pharm Sci. 1995 May;84(5):627-33. doi: 10.1002/jps.2600840520. J Pharm Sci. 1995. PMID: 7658356

9

Multiple-dose acetaminophen pharmacokinetics.

Sahajwalla CG, Ayres JW. Sahajwalla CG, et al. J Pharm Sci. 1991 Sep;80(9):855-60. doi: 10.1002/jps.2600800911. J Pharm Sci. 1991. PMID: 1800709

10

Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.

Sahajwalla CG, Bhatt AD, Bhatia SC, Bakshi R, Doshi KJ, Banavalikar MM, Bharucha ED, Marthak KV, Shah NN, Gupta KC, et al. Sahajwalla CG, et al. J Assoc Physicians India. 1991 Jul;39(7):546-8. J Assoc Physicians India. 1991. PMID: 1800501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters